BUCCI, Marco
 Distribuzione geografica
Continente #
EU - Europa 3.781
NA - Nord America 3.393
AS - Asia 1.440
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
SA - Sud America 4
Totale 8.643
Nazione #
US - Stati Uniti d'America 3.383
IT - Italia 1.051
CN - Cina 604
IE - Irlanda 573
UA - Ucraina 476
SE - Svezia 474
FR - Francia 414
SG - Singapore 335
TR - Turchia 325
GB - Regno Unito 289
DE - Germania 226
IN - India 134
FI - Finlandia 91
RU - Federazione Russa 90
BE - Belgio 23
PL - Polonia 15
IR - Iran 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
EG - Egitto 9
EU - Europa 8
CA - Canada 7
ES - Italia 7
GR - Grecia 7
HK - Hong Kong 6
IL - Israele 6
VN - Vietnam 6
ID - Indonesia 5
NL - Olanda 5
AL - Albania 3
AU - Australia 3
MX - Messico 3
MY - Malesia 3
SK - Slovacchia (Repubblica Slovacca) 3
BR - Brasile 2
EE - Estonia 2
JP - Giappone 2
LV - Lettonia 2
NO - Norvegia 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
LT - Lituania 1
MC - Monaco 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 8.643
Città #
Chandler 720
Jacksonville 565
Dublin 554
Singapore 279
Princeton 254
Southend 222
Izmir 195
Nanjing 156
Ashburn 137
Beijing 131
Ann Arbor 119
Wilmington 110
Dearborn 97
Cambridge 92
Chieti 89
New York 83
Boardman 69
Nanchang 63
Altamura 62
Santa Clara 56
Pescara 53
Milan 49
Los Angeles 48
Woodbridge 40
Munich 35
Shenyang 34
Rome 33
Hebei 31
Foggia 30
Tianjin 30
Washington 28
Houston 27
Brussels 22
Jinan 19
Kunming 19
Helsinki 17
Norwalk 17
Grevenbroich 14
Hangzhou 14
Auburn Hills 12
Florence 12
Jiaxing 12
Ningbo 12
Zhengzhou 12
Changsha 11
Orange 11
Bologna 10
Guangzhou 10
Kraków 10
San Mateo 10
Taizhou 10
Moscow 9
Seattle 9
Bari 8
Brno 8
Lanzhou 8
Mountain View 8
Padova 7
Spoltore 7
Andover 6
Augusta 6
Campobasso 6
Catania 6
Catanzaro 6
Changchun 6
Falls Church 6
Nocera Inferiore 6
Nuremberg 6
Simi Valley 6
Dong Ket 5
Grugliasco 5
Hefei 5
Legnano 5
Napoli 5
San Vito Chietino 5
Toronto 5
Brescia 4
Giugliano in Campania 4
Laurel 4
Lausanne 4
London 4
Monmouth Junction 4
Naples 4
Notaresco 4
Pomezia 4
Pontedera 4
Turin 4
Venice 4
Verona 4
Abbiategrasso 3
Bergamo 3
Bratislava 3
Cairo 3
Caserta 3
Ciampino 3
Duncan 3
Ferrara 3
Kashan 3
Kocaeli 3
Kyiv 3
Totale 4.989
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 453
VALUTAZIONE FUNZIONALE DELL'ATLETA: RAPPORTI TRA VO2 MAX E COMPOSIZIONE CORPOREA 134
Uneven accuracy of home blood pressure measurement: a multi-centric survey 122
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 120
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 114
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 107
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 106
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 106
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 101
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 98
Risultati immediati ed a lungo termine della rivascolarizzazione coronarica con PTCA con carattere ad autoperfusione vs PTCA con impianto di stent intracoronarico. 97
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 96
A unique microRNA signature associated with ischemic stroke in humans 95
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 91
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 91
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 90
A unique microRNA signature associated with plaque instability in humans. 89
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 88
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 88
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 88
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 87
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 87
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 86
Single coronary artery with a right origin: angiography identification of the R-II subgroup] 86
PROGETTO DI SCREENING SU 24.000 SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI. 86
uFollow-Up clinico di un gruppo di pazienti sottoposti a PTCA con impianto di stent intracoronarico. 84
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 84
L’automisurazione domiciliare della pressione: istruzioni per l’uso e sua utilità nel paziente anziano 83
The (K+)ey of the problem 81
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 81
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 80
Association between 5-lipoxygenase expression and plaque instability in humans. 80
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 79
Ipertensione arteriosa ed algosensibilità muscolare 79
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 79
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 79
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 78
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 78
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 78
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 77
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 77
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. 76
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 76
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 76
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 76
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 76
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 75
Linee guida cliniche per la prevenzione della cardiopatia ischemica nella ipercolesterolemia familiare: una patologia sotto-diagnosticata e sotto-trattata. Consensus. 74
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 74
PROGETTO DI SCREENING SU 24OOO SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI 73
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 72
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 71
DISAGREEMENT AMONG THE MAIN ALGORITHMS FOR CARDIOVASCULAR RISK ESTIMATION IN PATIENTS STRATIFICATION AND IN THEIR CORRELATION WITH ARTERIAL STIFFNESS 71
null 71
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 71
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 70
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 70
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 70
La stratificazione del rischio di sviluppare Diabete Mellito come strumento di diagnosi precoce: lo studio DIGA 70
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 70
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 70
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 70
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 69
Artrite reumatoide ed aumentato rischio cardiovascolare: impatto delle differenti terapie farmacologiche
 [Rheumatoid arthritis and increased cardiovascular risk: role of the different pharmacological therapies] 69
[ANALYSIS OF COSTS AND RESULTS OF PROSTAGLANDIN (PGE1 ALPHA-CYCLODESTRIN) THERAPY OF PERIPHERAL ARTERIAL DISEASES] 69
Arterial stiffness and global cardiovascular risk: results from a primary prevention population from Abruzzo (Italy) 68
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 68
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 67
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 67
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives 67
Possible indication of coronary risk trough discriminant functions. 66
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 66
Cardiovascular risk factor control in common clinical practice in a sample of patients in secondary prevention representative of the Abruzzo population 66
Muscle pain sensitivity in hypertensive patients with and without chronic pain 66
Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial. 65
Hypertension modulates miR-145 expression in human atherosclerotic plaques 65
Impact of hypertension on somatic pain sensitivity in chronic headache 65
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon 65
Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients 64
Cost-effectiveness of statins in primary and secondary prevention of cardiovascular event 63
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 63
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 62
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 62
null 61
COVID-19 and RAS: Unravelling an Unclear Relationship 61
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 59
Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study 59
Treatment of intermittent claudication with pentoxifylline: A 12-month, randomized trial: Walking distance and microcirculation 59
LA MALATTIA DI BARLOW NELLO SPORTIVO: TECNICA CHIRURGICA INNOVATIVA 57
Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry. 55
Effects of the total triterpenic fraction of Centella asiatica in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial 55
Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases 55
Impatto metabolico della terapia antiipertensiva nel paziente dislipidemico 54
Effects of lifestyle treatment on patients with metabolic syndrome and non-alcoholic hepatic steatosis evaluated with an ultrasonographic and elastographic approach 54
Correlation between Dutch lipid score and genetic diagnosis of FH in pediatric patients 54
The fascinating relationship between liver stiffness and cholesterol 54
Effects of Rosuvastatin on the expression of microRNAs and their putative targets in human atherosclerotic plaques: the QUASAR Study 53
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events 52
Nonalcoholic fatty liver and metabolic syndrome in Italy: Results from a multicentric study of the Italian Arteriosclerosis society 52
When a timely diagnosis means life: a precious lesson from a clinical case 52
Totale 7.933
Categoria #
all - tutte 32.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.056 0 0 32 51 106 104 155 128 76 173 170 61
2020/2021829 116 15 118 36 64 149 35 38 82 90 36 50
2021/2022744 34 20 22 153 39 14 28 39 62 29 122 182
2022/20232.129 165 256 119 223 214 414 130 159 274 44 70 61
2023/20241.188 82 44 75 40 85 333 225 44 35 64 25 136
2024/2025582 133 449 0 0 0 0 0 0 0 0 0 0
Totale 9.125